Metraipolis › archive › dc_79eef6bfec29

Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis — Europe PMC PPR:PPR1267829

Source: Europe PMC
Original: https://europepmc.org/article/PPR/PPR1267829
DOI: 10.64898/2026.03.05.26347694
License (as archived): solo-consultazione
Archived: 2026-10-09T06:29:21.211Z
SHA-256 of the archived text: 1957b6b683912a5f312bd99fbc1554a33859b3a9d08725e46b01f68d7d86ccd0
Stable URL of this page: https://metraipolis.com/documento/dc_79eef6bfec29

How to cite

Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis — Europe PMC PPR:PPR1267829 — Europe PMC, https://europepmc.org/article/PPR/PPR1267829 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_79eef6bfec29 (Metraipolis archive dc_79eef6bfec29, sha256 1957b6b683912a5f312bd99fbc1554a33859b3a9d08725e46b01f68d7d86ccd0)

BibTeX

@misc{dc79eef6bfec29,
  title = {Acceptability of cannabidiol as a treatment for people at clinical high risk for psychosis — Europe PMC PPR:PPR1267829},
  howpublished = {Europe PMC},
  url = {https://europepmc.org/article/PPR/PPR1267829},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_79eef6bfec29; sha256 1957b6b683912a5f312bd99fbc1554a33859b3a9d08725e46b01f68d7d86ccd0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/PPR/PPR1267829. Agents can read the archived copy with the MCP tool read_document.